{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:58:49Z","timestamp":1790211529182,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The huge burden of breast cancer (BC) necessitates the profound and accurate knowledge of the most recent cancer epidemiology and quality of care provided. We aimed to evaluate BC epidemiology and quality of care and examine the effects of socioeconomic development and healthcare expenditure on disparities in BC care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The results from the GLOBOCAN 2020 study were utilized to extract data on female BC, including incidence and mortality numbers, crude rates, and age-standardized rates [age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs)]. The mortality-to-incidence ratio (MIR) was calculated for different locations and socioeconomic stratifications to examine disparities in BC care, with higher values reflecting poor quality of care and vice versa. In both descriptive and analytic approaches, the human development index (HDI) and the proportion of current healthcare expenditure (CHE) to gross domestic product (CHE\/GDP%) were used to evaluate the values of MIR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Globally, 2,261,419 (95% uncertainty interval (UI): 2,244,260\u20132,278,710) new cases of female BC were diagnosed in 2020, with a crude rate of 58.5\/100,000 population, and caused 684,996 (675,493\u2013694,633) deaths, with a crude rate of 17.7. The WHO region with the highest BC ASIR (69.7) was Europe, and the WHO region with the highest ASMR (19.1) was Africa. The very high HDI category had the highest BC ASIR (75.6), and low HDI areas had the highest ASMR (20.1). The overall calculated value of female BC MIR in 2020 was 0.30, with Africa having the highest value (0.48) and the low HDI category (0.53). A strong statistically significant inverse correlation was observed between the MIR and HDI values for countries\/territories (Pearson's coefficient = \u22120.850, <jats:italic>p<\/jats:italic>-value &amp;lt; 0.001). A significant moderate inverse correlation was observed between the MIR and CHE\/GDP values (Pearson's coefficient = \u22120.431, <jats:italic>p<\/jats:italic>-value &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study highlighted that MIR of BC was higher in less developed areas and less wealthy countries. MIR as an indicator of the quality of care showed that locations with higher healthcare expenditure had better BC care. More focused interventions in developing regions and in those with limited resources are needed to alleviate the burden of BC and resolve disparities in BC care.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1137286","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:57:50Z","timestamp":1681275470000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020"],"prefix":"10.3389","volume":"11","author":[{"given":"Sina","family":"Azadnajafabad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Saeedi Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Delazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Mansourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4951","article-title":"Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019","author":"Azadnajafabad","year":"2022","journal-title":"Cancer Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"689562","DOI":"10.3389\/fonc.2021.689562","article-title":"The global, regional, and national burden and trends of breast cancer from 1990 to 2019: results from the global burden of disease study 2019","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fonc.2020.00650","article-title":"The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017","volume":"10","author":"Ji","year":"2020","journal-title":"Front Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13045-019-0828-0","article-title":"Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of disease study 2017","volume":"12","author":"Li","year":"2019","journal-title":"J Hematol Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2000.18.11.2327","article-title":"Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1200\/JCO.2005.03.3365","article-title":"Results of the national initiative for cancer care quality: how can we improve the quality of cancer care in the United States?","volume":"24","author":"Malin","year":"2006","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3&lt;701::AID-CNCR29&gt;3.0.CO;2-V","article-title":"Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool","volume":"88","author":"Malin","year":"2000","journal-title":"Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1200\/JCO.2005.05.948","article-title":"A process for measuring the quality of cancer care: the quality oncology practice initiative","volume":"23","author":"Neuss","year":"2005","journal-title":"J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.bprjmm4n","article-title":"Quality of care index (QCI)","author":"Mohammadi","year":"2020","journal-title":"Protocolsio."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/cncr.29228","article-title":"The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care","volume":"121","author":"Sunkara","year":"2015","journal-title":"Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e27414","DOI":"10.1097\/MD.0000000000027414","article-title":"Favorable colorectal cancer mortality-to-incidence ratios in countries with high expenditures on health and development index: a study based on GLOBOCAN database","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.21203\/rs.3.rs-155703\/v1","article-title":"Improved trends in the mortality-to-incidence ratios for liver cancer in countries with high development index and health expenditures","volume":"11","author":"Wang","year":"2021","journal-title":"Health Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e020618","DOI":"10.1136\/bmjopen-2017-020618","article-title":"Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries","volume":"8","author":"Lee","year":"2018","journal-title":"BMJ Open."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.3748\/wjg.v23.i44.7881","article-title":"Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries","volume":"23","author":"Tsai","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"713895","DOI":"10.3389\/fpubh.2021.713895","article-title":"Improvement in the mortality-to-incidence ratios for gastric cancer in developed countries with high health expenditures","volume":"9","author":"Yang","year":"2021","journal-title":"Front Pub Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12282-018-00941-4","article-title":"Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from global burden of disease study 2016","volume":"26","author":"Sharma","year":"2019","journal-title":"Breast Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"561376","DOI":"10.3389\/fonc.2021.561376","article-title":"National and subnational incidence, mortality, and years of life lost due to breast cancer in Iran: trends and age-period-cohort analysis since 1990","volume":"11","author":"Ataeinia","year":"2021","journal-title":"Front Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"40003","DOI":"10.1038\/srep40003","article-title":"Prostate cancer mortality-to-incidence ratios are associated with cancer care disparities in 35 countries","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41598-020-79367-y","article-title":"Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries","volume":"11","author":"Sung","year":"2021","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s12885-018-4698-6","article-title":"Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems","volume":"18","author":"Sung","year":"2018","journal-title":"BMC Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jid.3380050210","article-title":"Measuring development? The UNDP's human development index","volume":"5","author":"McGillivray","year":"1993","journal-title":"J Int Dev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0921-8009(97)00168-7","article-title":"The human development index: a critical review","volume":"25","author":"Sagar","year":"1998","journal-title":"Ecol Econ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.3390\/ijerph18116012","article-title":"Favorable lip and oral cancer mortality-to-incidence ratios in countries with high human development index and expenditures on health","volume":"18","author":"Sung","year":"2021","journal-title":"Int J Environ Res Pub Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10549-010-0827-x","article-title":"Health disparities in breast cancer: biology meets socioeconomic status","volume":"121","author":"Dunn","year":"2010","journal-title":"Breast Cancer Res Treat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1471-2407-9-364","article-title":"Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1524-4741.2008.00618.x","article-title":"Global health inequalities and breast cancer: an impending public health problem for developing countries","volume":"14","author":"Igene","year":"2008","journal-title":"Breast J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jbi\/wbaa093","article-title":"Health care disparities in breast cancer: the economics of access to screening, diagnosis, and treatment","volume":"2","author":"Mootz","year":"2020","journal-title":"J Breast Imag."},{"key":"B29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jwh.2013.4460","article-title":"Socioeconomic disparities in breast cancer treatment among older women","volume":"23","author":"White","year":"2002","journal-title":"J Women's Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-017-4490-3","article-title":"Socioeconomic status and breast cancer treatment","volume":"167","author":"Dreyer","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","article-title":"Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research","volume":"18","author":"Wheeler","year":"2013","journal-title":"Oncologist."},{"key":"B32","volume-title":"Global Cancer Observatory: Cancer Today Lyon","author":"Ferlay","year":"2020"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer."},{"key":"B34","unstructured":"Data Methods.2020"},{"key":"B35","unstructured":"2022"},{"key":"B36","unstructured":"Current health expenditure (CHE) as Percentage of Gross Domestic Product (GDP) (%): World Health Organization.2022"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the gather statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1158\/1055-9965.EPI-14-1286","article-title":"The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model","volume":"24","author":"Gangnon","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.breast.2013.07.013","article-title":"Breast cancer screening: controversy of impact","volume":"22","author":"Berry","year":"2013","journal-title":"Breast"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1715","DOI":"10.1016\/S2214-109X(22)00429-6","article-title":"Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"10","year":"2022","journal-title":"Lancet Global Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/annonc\/mdq633","article-title":"Advanced breast cancer incidence following population-based mammographic screening","volume":"22","author":"Autier","year":"2011","journal-title":"Annal. Oncol. Off J Eur Soc Med Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-013-2683-y","article-title":"The effect of country wealth on incidence of breast cancer","volume":"141","author":"Coccia","year":"2013","journal-title":"Breast Cancer Res Treat."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"DeSantis","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Lei","year":"2021","journal-title":"Cancer Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5306\/wjco.v5.i3.465","article-title":"Challenges to the early diagnosis and treatment of breast cancer in developing countries","volume":"5","author":"Unger-Salda\u00f1a","year":"2014","journal-title":"World J Clin Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1002\/cncr.27410","article-title":"Cancer burden in Africa and opportunities for prevention","volume":"118","author":"Jemal","year":"2012","journal-title":"Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1634\/theoncologist.2015-0429","article-title":"Breast cancer in Sub-Saharan Africa: challenges and opportunities to reduce mortality","volume":"21","author":"Pace","year":"2016","journal-title":"Oncologist."},{"key":"B49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13027-017-0124-y","article-title":"An update on the management of breast cancer in Africa","volume":"12","author":"Vanderpuye","year":"2017","journal-title":"Inf Cancer."},{"key":"B50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canep.2012.02.007","article-title":"The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality","volume":"36","author":"Youlden","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10549-020-06083-6","article-title":"Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018","volume":"187","author":"Sharma","year":"2021","journal-title":"Breast Cancer Res Treat."},{"key":"B52","volume-title":"Ensuring Quality Cancer Care","year":"1999"},{"key":"B53","doi-asserted-by":"publisher","first-page":"121873","DOI":"10.1155\/2012\/121873","article-title":"systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation","volume":"2012","author":"Sharma","year":"2012","journal-title":"J Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00268-009-0150-z","article-title":"Breast cancer care in developing countries","volume":"33","author":"Agarwal","year":"2009","journal-title":"World J Surg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1200\/JCO.2002.04.020","article-title":"Quality of breast cancer care: what do we know?","volume":"20","author":"Malin","year":"2002","journal-title":"J Clin Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.7314\/APJCP.2015.16.18.8439","article-title":"Incidence and mortality of breast cancer and their relationship with the human development index (HDI) in the world in 2012","volume":"16","author":"Ghoncheh","year":"2015","journal-title":"Asian Pac J Cancer Prev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/ijc.32406","article-title":"N'da G, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study","volume":"146","author":"Joko-Fru","year":"2020","journal-title":"Int J Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0158951","DOI":"10.1371\/journal.pone.0158951","article-title":"The outcome of breast cancer is associated with national human development index and health system attainment","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS ONE."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"46958019880696","DOI":"10.1177\/0046958019880696","article-title":"Health care expenditure burden of cancer care in the United States","volume":"56","author":"Park","year":"2019","journal-title":"Inquiry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.9778\/cmajo.20170144","article-title":"The economic burden of cancer care in Canada: a population-based cost study","volume":"6","author":"de Oliveira","year":"2018","journal-title":"CMAJ open."},{"key":"B62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12904-019-0426-5","article-title":"Catastrophic health expenditure of cancer patients at the end-of-life: a retrospective observational study in China","volume":"18","author":"Leng","year":"2019","journal-title":"BMC Palliat Care."},{"key":"B63","doi-asserted-by":"publisher","first-page":"S489","DOI":"10.1016\/j.amepre.2015.09.002","article-title":"Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012","volume":"49","author":"Guy","year":"2015","journal-title":"Am J Prev Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40258-021-00672-2","article-title":"Incidence of catastrophic health expenditure and its determinants in cancer patients: a systematic review and meta-analysis","volume":"19","author":"Doshmangir","year":"2021","journal-title":"Appl Health Econ Health Policy."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1137286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:57:54Z","timestamp":1681275474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1137286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":64,"alternative-id":["10.3389\/fpubh.2023.1137286"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1137286","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"article-number":"1137286"}}